OGF is manufactured at the same GMP certified facility Dr
Medical Evaluation Our medical team reviews your health history and may order lab work
The benefits of GLP-1 and GIP receptor agonists have been established in preclinical models, providing a foundation for clinical research
Which Path Is Right for You
This secondary analysis of the STEP-HFpEF (Semaglutide Treatment Effect in People with Obesity and HFpEF) program reveals that semaglutide provides benefits for men and women that do not track directly with weight loss, suggesting the drug may also have weight-loss independent effects on the cardiovascular system
Nuanced findings: Gender and lipid level interactions, visceral fat, inflammation, and heart failure Not everyone with high Lp(a) has the same level of risk, and some people with high Lp(a) will never have atherosclerosis or a heart attack